Clinical Trials for Recurrent Hodgkin Lymphoma

Find clinical trials for recurrent hodgkin lymphoma. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

NCT ID: NCT05272384

This clinical trial is studying a new treatment for patients with certain types of B-cell lymphoma, specifically those whose cancer has returned after treatment or who have not responded to previou...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States, Birmingham, Alabama, United States +8 more

Personalized NK Cell Therapy in CBT

NCT ID: NCT02727803

This clinical trial is looking at a new treatment called personalized natural killer (NK) cell therapy for patients with certain types of blood cancers, including leukemia, lymphoma, and myelodyspl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

NCT ID: NCT04640779

This clinical trial is studying a combination of two medications, low-dose selinexor and choline salicylate, to find out their safety and the best dose to use for treating patients with certain typ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT ID: NCT03418038

This clinical trial is studying the combined effect of ascorbic acid (a form of vitamin C) and chemotherapy on patients with certain types of lymphoma that have either come back after treatment or ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Iowa City, Iowa, United States +5 more

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

NCT ID: NCT04871607

This clinical trial is studying a new treatment for patients with Hodgkin lymphoma that has either not responded to previous treatments or has come back after treatment. The researchers are combini...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions